Cadele

Medicinal product

(Invented) name

Cadele

Active substance (s)

Levonorgestrelis

Strength

0,75 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AD01, Levonorgestrel

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2019-03-07

Date of renewal

2023-10-10

Documents

4349 Pakuotės lapelis 2024 08 02.docx

4349 Cadele 0,75mg PCS II PL 2024 08 02.docx

Cadele_tab_viešas_AR.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Levonorgestrelis	0,75 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101094	87205	1087205	lizdinė plokštelė	N2		Nereceptinis	LT/1/19/4349/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-10-10	Perregistruotas
2019-03-07	Registruotas